NAMS Earnings Date: Nov 4, 2026 (Estimated) — NewAmsterdam Pharma Company N.V.
NASDAQ · Healthcare · Biotechnology
Updated
When is NAMS's next earnings date?
NewAmsterdam Pharma Company N.V. (NAMS) is expected to report Q3 2026 earnings on Wednesday, November 4, 2026 at 8:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.49 on revenue of $7.5M.
How did NAMS do in its last earnings report?
In its most recent report on Aug 5, 2026 (Q2 2026), NewAmsterdam Pharma Company N.V. posted EPS of -$0.52 versus the -$0.48 estimate, a miss of 20.9%. Revenue was $3.7M against a $1.9M estimate. The stock's 1-day post-earnings move was -0.5%.
How much does NAMS stock move after earnings?
NAMS beat EPS estimates in 2 of its last 5 reported quarters. Over the last 6 reports the stock moved an average of 6.3% (up or down) in the day after earnings.
About NewAmsterdam Pharma Company N.V.
NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with cardiometabolic disease. It is developing Obicetrapib, an oral low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in various clinical trials as a monotherapy and a combination therapy with ezetimibe for lowering LDL-C for cardiovascular diseases. The company also develops Obicetrapib which is in Phase 2a clinical trial for Alzheimer’s disease. NewAmsterdam Pharma Company N.V. is headquartered in Naarden, the Netherlands.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-05 | Q2 2026 | -0.48 | -0.52 | -20.93% | $3.7M | ❌ Miss | -0.47% | +0.25% | -7.11% |
| 2026-05-07 | Q1 2026 | -0.43 | -0.40 | +6.98% | $3.0M | ✅ Beat | +12.46% | +21.81% | +1.71% |
| 2026-02-18 | Q4 2025 | -0.38 | -0.63 | -65.79% | $32,000 | ❌ Miss | +1.48% | +2.19% | -16.46% |
| 2025-11-05 | Q3 2025 | -0.36 | -0.61 | -69.44% | $348,000 | ❌ Miss | +4.37% | +9.20% | -1.86% |
| 2025-08-06 | Q2 2025 | -0.46 | -0.15 | +67.39% | $19.1M | ✅ Beat | +8.70% | +15.05% | +18.09% |
| 2025-02-26 | Q4 2024 | — | -0.51 | — | $8.6M | — | +10.23% | +20.25% | +26.17% |
| 2022-11-09 | — | -0.59 | — | $5.5M | — | — | — | — | |
| 2022-08-11 | — | 0.75 | — | $49.0M | — | — | — | — |
Showing last 8 quarters.